Aerobic Capacity Training During Hematologic Rehabilitation

Abstract

Aerobic capacity training is an increasingly important component of hematologic rehabilitation for patients recovering from leukemia, lymphoma, plasma-cell disorders, myelodysplastic syndromes, and hematopoietic stem-cell transplantation. Disease-related inflammation, anemia, treatment toxicity, prolonged hospitalization, corticosteroid exposure, infection, and physical inactivity can substantially reduce cardiorespiratory fitness. Low aerobic capacity is associated with impaired functional independence, poorer treatment tolerance, greater symptom burden, and delayed return to work and social participation. Carefully prescribed aerobic exercise can improve peak oxygen uptake, walking capacity, muscular endurance, fatigue, mood, and health-related quality of life while supporting metabolic and cardiovascular health. This review summarizes the disease burden, biological mechanisms, risk factors, clinical manifestations, assessment strategies, treatment principles, emerging approaches, and guideline-based considerations relevant to aerobic capacity training in hematologic rehabilitation. Exercise prescription should be individualized according to blood counts, cardiopulmonary status, infection risk, treatment phase, vascular access, musculoskeletal limitations, and patient preferences. Close coordination among hematologists, rehabilitation physicians, physiotherapists, nurses, and exercise specialists is essential for safe implementation.

Introduction

Hematologic malignancies and their treatments produce complex and persistent limitations in physical function. Patients may experience reduced activity beginning at diagnosis and continuing through chemotherapy, radiotherapy, immunotherapy, transplantation, maintenance treatment, and survivorship. Although disease control remains the primary clinical objective, progressive deconditioning can become an independent determinant of disability. Aerobic capacity, commonly estimated through peak oxygen uptake, ventilatory thresholds, submaximal walking tests, or field-based functional assessments, reflects the integrated performance of the pulmonary, cardiovascular, hematologic, neuromuscular, and metabolic systems.

Hematologic rehabilitation aims to preserve or restore physical function while minimizing treatment-related complications. Aerobic capacity training includes structured activities that use large muscle groups rhythmically for sustained periods, such as walking, cycling, rowing, or low-impact stepping. Programs may be continuous or interval-based and can be delivered in hospital, outpatient, community, or home settings. The therapeutic objective is not athletic performance but restoration of physiological reserve, tolerance of daily activities, and capacity to participate safely in cancer treatment and recovery.

Epidemiology / Disease Burden

Reduced exercise capacity is common across hematologic diseases, although its magnitude varies according to disease subtype, stage, treatment intensity, age, comorbidity, and baseline fitness. Patients receiving intensive chemotherapy or hematopoietic stem-cell transplantation often experience marked reductions in daily steps, mobility, and cardiopulmonary fitness during hospitalization. Survivors may continue to report fatigue, exertional dyspnea, weakness, sleep disturbance, and reduced participation months or years after treatment completion.

The clinical burden extends beyond subjective symptoms. Low cardiorespiratory fitness is associated with dependence in activities of daily living, prolonged recovery after hospitalization, greater vulnerability to falls, and reduced ability to tolerate physiological stress. In selected populations, impaired fitness may also influence readiness for transplantation or intensive therapy. Sedentary behavior can promote insulin resistance, weight gain, sarcopenia, endothelial dysfunction, and cardiovascular risk, thereby compounding late effects of cancer treatment. Because these problems are potentially modifiable, systematic assessment and rehabilitation represent clinically meaningful aspects of comprehensive hematologic care.

Pathophysiology

The reduction in aerobic capacity is multifactorial. Anemia lowers arterial oxygen content and increases cardiac workload during exertion. Thrombocytopenia may restrict exercise intensity because of bleeding concerns, while neutropenia and immune dysfunction can increase infection-related precautions. Malignant disease and treatment can induce systemic inflammation, which contributes to mitochondrial dysfunction, altered muscle protein turnover, impaired endothelial function, and central fatigue.

Chemotherapy may cause direct myocardial injury, autonomic disturbance, peripheral neuropathy, myopathy, or pulmonary toxicity. Radiotherapy involving the chest can affect cardiac and pulmonary structures, while corticosteroids may promote proximal muscle weakness, metabolic complications, and loss of lean mass. Hematopoietic transplantation adds conditioning-related toxicity, graft-versus-host disease, prolonged immunosuppression, and extended inactivity. Deconditioning reduces stroke volume, skeletal-muscle oxidative capacity, capillary density, and neuromuscular efficiency. Consequently, a given external workload requires a greater relative physiological effort, reinforcing activity avoidance and creating a cycle of worsening disability.

Risk Factors

Important risk factors include advanced age, pre-existing cardiovascular or pulmonary disease, obesity, frailty, low baseline physical activity, malnutrition, sarcopenia, chronic pain, depression, sleep disturbance, and persistent treatment-related fatigue. Disease-specific factors include high tumor burden, prolonged hospitalization, relapse, severe anemia, recurrent infection, graft-versus-host disease, and complications affecting the heart, lungs, nerves, or musculoskeletal system.

Medication exposure should be reviewed carefully. Anthracyclines, certain targeted therapies, immune-mediated treatments, corticosteroids, and some conditioning regimens may affect exercise tolerance through cardiovascular, pulmonary, endocrine, or neuromuscular mechanisms. Central venous catheters, bone lesions, osteoporosis, and bleeding risk may alter the choice of exercise mode. Risk stratification should therefore be dynamic; a patient suitable for moderate continuous exercise during survivorship may require low-intensity interval activity, bedside mobility, or temporary exercise restriction during acute treatment complications.

Clinical Features

Patients commonly report exertional fatigue, breathlessness, reduced walking distance, early muscle exhaustion, dizziness, palpitations, and difficulty climbing stairs or performing household tasks. Functional limitations may be accompanied by reduced concentration, anxiety about exertion, loss of confidence, and fear of infection or injury. Some individuals have few spontaneous complaints because they have progressively reduced activity to avoid symptoms; objective testing can therefore reveal clinically important impairment that is not apparent during routine consultation.

Clinicians should distinguish treatment-related deconditioning from potentially reversible or urgent causes of exercise intolerance. New chest pain, syncope, disproportionate dyspnea, sustained palpitations, fever, unilateral limb swelling, rapidly progressive weakness, or unexplained oxygen desaturation requires prompt medical evaluation rather than routine exercise progression. A careful symptom history should include exertional pattern, recovery time, orthostatic symptoms, bleeding, infection exposure, neuropathic symptoms, and changes in functional independence.

Diagnosis

Assessment begins with medical history, physical examination, medication review, treatment phase, and review of complete blood counts and relevant biochemical results. Baseline evaluation should consider cardiovascular risk, pulmonary symptoms, musculoskeletal stability, neurological function, nutritional status, and psychosocial barriers. Standardized tools such as the six-minute walk test, incremental shuttle walk test, timed up-and-go, sit-to-stand testing, activity questionnaires, and patient-reported fatigue scales provide practical information in many clinical settings.

Cardiopulmonary exercise testing is the most comprehensive method for characterizing peak oxygen uptake, ventilatory efficiency, anaerobic threshold, circulatory limitation, and abnormal blood-pressure or heart-rate responses. It is particularly valuable when symptoms are disproportionate, cardiotoxic exposure is substantial, or the exercise prescription requires greater precision. Resting electrocardiography, echocardiography, pulmonary function testing, oxygen saturation measurement, and targeted imaging should be selected according to symptoms and treatment history. Diagnosis of anemia, infection, endocrine dysfunction, nutritional deficiency, cardiomyopathy, pulmonary disease, or severe sarcopenia is essential because these conditions may require treatment before or alongside rehabilitation.

Treatment & Management

Aerobic training should follow an individualized, progressive, and monitored prescription. Walking and stationary cycling are often practical initial modes because intensity can be adjusted rapidly and equipment requirements are modest. For patients with severe deconditioning, short bouts of one to five minutes separated by active or passive recovery may be better tolerated than continuous exercise. As symptoms stabilize, duration can generally increase before intensity, with progression guided by perceived exertion, heart-rate response, oxygen saturation, symptoms, and recovery time.

Moderate-intensity exercise is frequently appropriate for medically stable patients, but an absolute intensity target is not suitable for every patient. The rating of perceived exertion, talk test, and individualized physiological thresholds can support safer prescription when anemia, chronotropic limitation, autonomic dysfunction, or medications alter heart-rate interpretation. Interval training may permit a greater accumulated workload with less sustained distress, although it should be introduced cautiously in patients with unstable cardiopulmonary disease or poor symptom recognition.

Training should be integrated with resistance exercise, flexibility, balance work, breathing strategies, and functional task practice. Resistance training is particularly important when sarcopenia, corticosteroid-associated weakness, or transplant-related muscle loss is present. Warm-up and cool-down periods, hydration, appropriate footwear, infection-control procedures, and environmental safety are essential. Exercise sessions should be postponed or modified during acute fever, hemodynamic instability, uncontrolled pain, significant bleeding, severe symptomatic anemia, or other clinically important complications. Blood-count thresholds and precautions should follow institutional policy and specialist judgment rather than a universal rule.

During inpatient treatment, rehabilitation may include bedside cycling, corridor walking, supervised mobility, and interruption of prolonged bed rest. In outpatient care, structured center-based or home-based programs can be supported by activity logs, remote monitoring, telephone coaching, or digital platforms. Adherence improves when goals are functional and personally meaningful, such as walking to appointments, managing stairs, or resuming employment. Fatigue education should emphasize energy conservation without promoting unnecessary inactivity. Nutritional support, sleep management, psychological care, and symptom-directed medical treatment enhance the response to exercise.

Recent Advances / Emerging Therapies

Recent rehabilitation models emphasize early prehabilitation, beginning before transplantation or intensive treatment when feasible. Prehabilitation may improve baseline reserve and help patients enter therapy with better mobility and self-management skills. Hybrid programs that combine supervised sessions with home exercise can extend access while retaining professional oversight. Wearable activity monitors and remote physiological assessments offer opportunities to identify declining mobility earlier, although their data should complement rather than replace clinical evaluation.

Research is also examining high-intensity interval training, blood-flow-informed exercise prescription, neuromuscular electrical stimulation for patients unable to sustain conventional activity, and precision rehabilitation based on cardiopulmonary testing, biomarkers, frailty measures, and treatment exposures. These approaches remain context-dependent. Their use should be limited to appropriately screened patients and delivered by teams familiar with hematologic complications. Future studies should report hematologic safety events, treatment interruptions, hospitalization, adherence, long-term function, and patient-reported outcomes in addition to peak oxygen uptake.

Guideline Recommendations

Major oncology and exercise-medicine guidance generally supports regular physical activity for cancer survivors and recommends individualized aerobic, resistance, and flexibility training when medically appropriate. In hematologic practice, recommendations should be adapted to disease status, blood counts, infection risk, bone health, cardiopulmonary complications, vascular access, and transplant-related immunosuppression. Medical clearance is especially important for patients with suspected cardiotoxicity, significant symptoms, unstable disease, severe frailty, or major comorbidity.

Clinicians should prescribe exercise using the principles of frequency, intensity, time, and type, with gradual progression and regular reassessment. A multidisciplinary team should establish stop criteria, emergency procedures, environmental precautions, and communication pathways with the treating hematologist. Exercise should not be withheld solely because a patient has a hematologic malignancy; instead, the program should be modified according to current clinical risk. Documentation should include baseline function, prescribed dose, adverse symptoms, blood-count considerations, adherence, and measurable outcomes.

Conclusion

Aerobic capacity training is a clinically relevant and adaptable intervention throughout hematologic rehabilitation. By counteracting deconditioning, improving oxygen transport and skeletal-muscle efficiency, and restoring confidence in movement, structured exercise can reduce functional disability and enhance quality of life. Safe delivery requires comprehensive assessment, close attention to treatment-related risks, individualized progression, and collaboration between hematology and rehabilitation professionals. Early referral, objective functional testing, integration with resistance training and symptom management, and continued reassessment should become routine elements of survivorship and supportive cancer care. Further high-quality research should define disease-specific training thresholds and clarify how exercise influences treatment tolerance, cardiovascular outcomes, hospitalization, and long-term survival.